Article
Wnt7a is required for regeneration of dystrophic skeletal muscle
19 Dec 2024
Abstract excerpt
Intramuscular injection of Wnt7a has been shown to accelerate and augment skeletal muscle regeneration and to ameliorate dystrophic progression in mdx muscle, a model for Duchenne muscular dystrophy (DMD). Here, we assessed muscle regeneration and function in wild type (WT) and mdx mice where Wnt7a was deleted in muscle using a conditional Wnt7a floxed allele and a Myf5-Cre driver. We found that both WT and mdx...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
